SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-211319
Filing Date
2020-08-06
Accepted
2020-08-06 07:20:59
Documents
3
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d24604d8k.htm 8-K 27040
2 EX-99.1 d24604dex991.htm EX-99.1 76654
3 GRAPHIC g24604snap2.jpg GRAPHIC 4850
  Complete submission text file 0001193125-20-211319.txt   111882
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 201079809
SIC: 2834 Pharmaceutical Preparations